Adjuvant Palbociclib for ER+ Breast Cancer (PALLAS Trial (ABCSG-42/AFT-05/BIG-14-13): A Preplanned Analysis of the Stage IIA cohort
   Google Scholar   
Citation:
J Clin Oncol vol 40 (36 suppl) 390216
Meeting Instance:
ASCO PS (Oct) 2022
Year:
2022
Type:
Abstract
Sub type:
Funding:
AFT
Endpoint:
Secondary
Analysis:
Preliminary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
4070  
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
Pfizer  
Grants:
AFT, ABCSG, PrECOG, NSABP Foundation, GBG, BIG  
Corr. Author:
 
Authors:
                                                                       
Networks:
CA824, LAPS-CT018, LAPS-MA036, LAPS-MD017, LAPS-MN026, LAPS-NY016, LAPS-PA015   
Study
AFT-05
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: